Molecular staging of colorectal cancer: New paradigm or waste of time?

Expert Opinion on Medical Diagnostics

Volumn 1, Issue 1, 2007, Pages 31-45

  Murphy, Jamie ^a   Dorudi, Sina ^a   Bustin, Stephen A ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

colorectal cancer; histopathology; microarray; molecular staging; PCR

Indexed keywords

EID: 57749197297     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.1.1.31     Document Type: Review

References (124)

1. QUIRKE P, MORRIS E: Reporting colorectal cancer. Histopathology (2007) 50 (1): 103-112. (Pubitemid 44953402)
2. NELSON H, PETRELLI N, CARLIN A et al.: Guidelines 2000 for colon and rectal cancer surgery. J. Natl. Cancer Inst. (2001) 93 (8): 583-596. (Pubitemid 32409626)
3. QUIRKE P, WILLIAMS GT, ECTORS N et al.: The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol. (2007) 8 (7): 651-657. (Pubitemid 46995637)
4. JEMAL A, MURRAY T, WARD E et al.: Cancer statistics, 2005. CA Cancer J. Clin. (2005) 55 (1): 10-30. (Pubitemid 40310185)
5. RATTO C, SOFO L, IPPOLITI M et al.: Prognostic factors in colorectal cancer. Literature review for clinical application. Dis. Colon Rectum (1998) 41 (8): 1033-1049. (Pubitemid 28369295)
6. MIDGLEY R, KERR DJ: Adjuvant chemotherapy for stage II colorectal cancer: the time is right! Nat. Clin. Pract. Oncol. (2005) 2 (7): 364-369. (Pubitemid 43118123)
7. SEBAG-MONTEFIORE D: Developments in the use of chemoradiotherapy in rectal cancer. Colorec. Dis. (2006) 8 (Suppl. 3): 4-17.
8. STEIN U, SCHLAG PM: Clinical, biological, and molecular aspects of metastasis in colorectal cancer. Recent Results Cancer Res. (2007) 176: 1-80.
9. JASS JR, O BRIEN MJ, RIDDELL RH et al.: Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum. Pathol. (2007) 38 (4): 537-545.
10. DUFFY MJ, VAN DALEN A, HAGLUND C et al.: Tumour markers in colorectal cancer: European group on tumour markers (EGTM) guidelines for clinical use. Eur. J. Cancer (2007).
11. ROUKOS DH, MURRAY S, BRIASOULIS E: Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer. Cancer Biol. Ther. (2007) 6 (3): 308-312. (Pubitemid 47328293)
12. MAURER GD, LEUPOLD JH, SCHEWE DM et al.: Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer. Clin. Cancer Res. (2007) 13 (4): 1123-1132. (Pubitemid 46424051)
13. BARRATT PL, SEYMOUR MT, STENNING SP et al.: DNA markers predicting benefi t from adjuvant fluorouracil in patients with colon cancer: a molecular study. Lancet (2002) 360 (9343): 1381-1391. (Pubitemid 35341303)
14. AL-MULLA F, HAGAN S, BEHBEHANI AI et al.: Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J. Clin. Oncol. (2006) 24 (36): 5672-5679. (Pubitemid 46631308)
15. VOGELSTEIN B, FEARON ER, HAMILTON SR et al.: Genetic alterations during colorectal-tumor development. N. Engl. J. Med. (1988) 319 (9): 525-532.
16. TAKAYAMA T, MIYANISHI K, HAYASHI T et al.: Colorectal cancer: genetics of development and metastasis. J. Gastroenterol. (2006) 41 (3): 185-192.
17. THIERY JP: Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. (2003) 15 (6): 740-746. (Pubitemid 37487967)
18. LOSI L, BAISSE B, BOUZOURENE H et al.: Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis (2005) 26 (5): 916-922. (Pubitemid 41214320)
19. AL-MULLA F, KEITH WN, PICKFORD IR et al.: Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer (1999) 24 (4): 306-314. (Pubitemid 29115868)
20. BRABLETZ T, JUNG A, REU S et al.: Variable-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. USA (2001) 98 (18): 10356-10361. (Pubitemid 32803024)
21. BARKER N, CLEVERS H: Tumor environment: a potent driving force in colorectal cancer? Trends Mol. Med. (2001) 7 (12): 535-537. (Pubitemid 33127135)
22. BISSELL MJ, RADISKY D: Putting tumours in context. Nat. Rev. Cancer (2001) 1 (1): 46-54. (Pubitemid 33741880)
23. HUNTER KW, CRAWFORD NP: Germ line polymorphism in metastatic progression. Cancer Res. (2006) 66 (3): 1251-1254. (Pubitemid 43259899)
24. FISHER ER, TURNBULL RB Jr: The cytologic demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma. Surg. Gynecol. Obstet. (1955) 100 (1): 102-108.
25. ENGELL HC: Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation. Acta Chir. Scand. Suppl. (1955) 201: 1-70.
26. GRIFFITHS JD, MCKINNA JA, ROWBOTHAM HD et al.: Carcinoma of the colon and rectum: circulating malignant cells and five-year survival. Cancer (1973) 31 (1): 226-236.
27. BUSTIN SA: Nucleic acid Quantification and disease outcome prediction in colorectal cancer. Personalized Med. (2006) 3 (2): 207-216.
28. RAMASWAMY S, ROSS KN, LANDER ES et al.: A molecular signature of metastasis in primary solid tumors. Nat. Genet. (2003) 33 (1): 49-54. (Pubitemid 36068681)
29. AHMED FE: Molecular markers that predict response to colon cancer therapy. Expert Rev. Mol. Diagn. (2005) 5 (3): 353-375. (Pubitemid 40686096)
30. RIBIC CM, SARGENT DJ, MOORE MJ et al.: Tumor microsatellite-instability status as a predictor of benefi t from fluorouracil-based adjuvant chemotherapy for colon cancer. N. Engl. J. Med. (2003) 349 (3): 247-257. (Pubitemid 36859476)
31. HAWKINS NJ, TOMLINSON I, MEAGHER A et al.: Microsatellite-stable diploid carcinoma: a biologically distinct and aggressive subset of sporadic colorectal cancer. Br. J. Cancer (2001) 84 (2): 232-236. (Pubitemid 32113451)
32. BUSTIN SA, DORUDI S: Gene expression profiling for molecular staging and prognosis prediction in colorectal cancer. Expert Rev. Mol. Diagn. (2004) 4 (5): 599-607. (Pubitemid 39220835)
33. CUMMINS JM, VELCULESCU VE: Implications of micro-RNA profiling for cancer diagnosis. Oncogene (2006) 25 (46): 6220-6227. (Pubitemid 44527853)
34. NGUYEN DX, MASSAGUE J: Genetic determinants of cancer metastasis. Nat. Rev. Genet. (2007) 8 (5): 341-352. (Pubitemid 46625811)
35. FIDLER IJ: The biology of cancer metastasis or, you cannot fix it if you do not know how it works . Bioessays (1991) 13 (10): 551-554. (Pubitemid 121000506)
36. HABERMANN JK, PAULSEN U, ROBLICK UJ et al.: Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer (2007) 46 (1): 10-26. (Pubitemid 44772868)
37. CONSORTIUM TWTCC: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 447 (7145): 661-678.
38. BOOTH RA: Minimally invasive biomarkers for detection and staging of colorectal cancer. Cancer Lett. (2007) 249 (1): 87-96. (Pubitemid 46437280)
39. TING AH, MCGARVEY KM, BAYLIN SB: The cancer epigenome - components and functional correlates. Genes Dev. (2006) 20 (23): 3215-3231. (Pubitemid 44904843)
40. MIRANDA E, DESTRO A, MALESCI A et al.: Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br. J. Cancer (2006) 95 (8): 1101-1107. (Pubitemid 44606839)
41. WENDT MK, JOHANESEN PA, KANG-DECKER N et al.: Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene (2006) 25 (36): 4986-4997.
42. BANDRES E, CUBEDO E, AGIRRE X et al.: Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer (2006) 5: 9.
43. CUMMINS JM, HE Y, LEARY RJ et al.: The colorectal microRNAome. Proc. Natl. Acad. Sci. USA (2006) 103 (10): 3687-3692. (Pubitemid 43376616)
44. XU WH, CHEN YD, HU Y et al.: Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis. Zhonghua Zhong Liu Za Zhi (2006) 28 (10): 753-757.
45. VILLANUEVA J, PHILIP J, ENTENBERG D et al.: Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal. Chem. (2004) 76 (6): 1560-1570. (Pubitemid 38338398)
46. SMITH FM, GALLAGHER WM, FOX E et al.: Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy. Ann. Surg. (2007) 245 (2): 259-266. (Pubitemid 46151655)
47. LENGAUER C, KINZLER KW, VOGELSTEIN B: Genetic instability in colorectal cancers. Nature (1997) 386 (6625): 623-627. (Pubitemid 27175430)
48. CUNNINGHAM JM, CHRISTENSEN ER, TESTER DJ et al.: Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. (1998) 58 (15): 3455-3460. (Pubitemid 28371090)
49. SAMOWITZ WS, CURTIN K, MA KN et al.: Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomarkers Prev. (2001) 10 (9): 917-923. (Pubitemid 32844897)
50. BENATTI P, GAFA R, BARANA D et al.: Microsatellite instability and colorectal cancer prognosis. Clin. Cancer Res. (2005) 11 (23): 8332-8340. (Pubitemid 41746945)
51. SALAHSHOR S, KRESSNER U, FISCHER H et al.: Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br. J. Cancer (1999) 81 (2): 190-193. (Pubitemid 29423694)
52. FEELEY KM, FULLARD JF, HENEGHAN MA et al.: Microsatellite instability in sporadic colorectal carcinoma is not an indicator of prognosis. J. Pathol. (1999) 188 (1): 14-17. (Pubitemid 29197308)
53. CURTIS LJ, GEORGIADES IB, WHITE S et al.: Specific patterns of chromosomal abnormalities are associated with RER status in sporadic colorectal cancer. J. Pathol. (2000) 192 (4): 440-445.
54. GEORGIADES IB, CURTIS LJ, MORRIS RM et al.: Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instability. Oncogene (1999) 18 (56): 7933-7940. (Pubitemid 30050553)
55. YAO T, KAJIWARA M, KOUZUKI T et al.: Villous tumor of the colon and rectum with special reference to roles of p53 and bcl-2 in adenoma-carcinoma sequence. Pathol. Int. (1999) 49 (5): 374-382. (Pubitemid 29309666)
56. TANG R, CHANGCHIEN CR, WU MC et al.: Colorectal cancer without high microsatellite instability and chromosomal instability - an alternative genetic pathway to human colorectal cancer. Carcinogenesis (2004) 25 (5): 841-846. (Pubitemid 38618539)
57. CHAN TL, CURTIS LC, LEUNG SY et al.: Early-onset colorectal cancer with stable microsatellite DNA and near-diploid chromosomes. Oncogene (2001) 20 (35): 4871-4876. (Pubitemid 32803157)
58. JONES AM, DOUGLAS EJ, HALFORD SE et al.: Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma. Oncogene (2005) 24 (1): 118-129. (Pubitemid 40143871)
59. GHADIMI BM, GRADE M, MONKEMEYER C et al.: Distinct chromosomal profiles in metastasizing and non-metastasizing colorectal carcinomas. Cell Oncol. (2006) 28 (5-6): 273-281. (Pubitemid 44950098)
60. AL-MULLA F, BEHBEHANI AI, BITAR MS et al.: Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse. Mod. Pathol. (2006) 19 (5): 648-658.
61. GHADIMI BM, GRADE M, LIERSCH T et al.: Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer. Clin. Cancer Res. (2003) 9 (5): 1808-1814. (Pubitemid 36554608)
62. DIEP CB, PARADA LA, TEIXEIRA MR et al.: Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis. Genes Chromosomes Cancer (2003) 36 (2): 189-197. (Pubitemid 36109562)
63. KNOSEL T, SCHLUNS K, STEIN U et al.: Chromosomal alterations during lymphatic and liver metastasis formation of colorectal cancer. Neoplasia (2004) 6 (1): 23-28. (Pubitemid 38391946)
64. BAISSE B, BOUZOURENE H, SARAGA EP et al.: Intratumor genetic heterogeneity in dvanced human colorectal adenocarcinoma. Int. J. Cancer (2001) 93 (3): 346-352. (Pubitemid 32592052)
65. BUSTIN SA, DORUDI S: Molecular assessment of tumour stage and disease recurrence using PCR- based assays. Mol. Med. Today (1998) 4 (9): 389-396. (Pubitemid 28411033)
66. VLEMS FA, WOBBES T, PUNT CJ et al.: Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer. Anticancer Res. (2003) 23 (1B): 523-530. (Pubitemid 36358445)
67. HAYASHI N, ITO I, YANAGISAWA A et al.: Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet (1995) 345 (8960): 1257-1259.
68. CLARKE GA, RYAN E, CROWE JP et al.: Tumour-derived mutated K-ras codon 12 expression in regional lymph nodes of stage II colorectal cancer patients is not associated with increased risk of cancer-related death. Int. J. Colorec. Dis. (2001) 16 (2): 108-111. (Pubitemid 32318345)
69. LEON SA, SHAPIRO B, SKLAROFF DM et al.: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. (1977) 37 (3): 646-650. (Pubitemid 8051621)
70. ANKER P, LEFORT F, VASIOUKHIN V et al.: K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology (1997) 112 (4): 1114-1120. (Pubitemid 27157521)
71. LECOMTE T, BERGER A, ZINZINDOHOUE F et al.: Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int. J. Cancer (2002) 100 (5): 542-548. (Pubitemid 34816154)
72. FUJITA S, SUGANO K, FUKAYAMA N et al.: Detection of K-ras point mutations in mesenteric venous blood from colorectal cancer patients by enriched polymerase chain reaction and single-strand conformation polymorphism analysis. Jpn. J. Clin. Oncol. (1996) 26 (6): 417-421. (Pubitemid 126471800)
73. RYAN BM, MCMANUS RO, DALY JS et al.: Serum mutant K-ras in the colorectal adenoma-to-carcinoma sequence. Implications for diagnosis, postoperative follow-up, and early detection of recurrent disease. Ann. NY Acad. Sci. (2000) 906: 9-30.
74. TIEN YW, LEE PH, WANG SM et al.: Simultaneous detection of colonic epithelial cells in portal venous and peripheral blood during colorectal cancer surgery. Dis. Colon Rectum (2002) 45 (1): 23-29.
75. MOCELLIN S, ROSSI CR, PILATI P et al.: Quantitative real-time PCR: a powerful ally in cancer research. Trends Mol. Med. (2003) 9 (5): 189-195. (Pubitemid 36713388)
76. BUSTIN SA, SIDDIQI S, AHMED S et al.: Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients. Int. J. Cancer (2004) 108 (3): 412-417. (Pubitemid 37549607)
77. KEILHOLZ U, WILLHAUCK M, RIMOLDI D et al.: Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a qualityassurance initiative of the EORTC melanoma cooperative group. Eur. J. Cancer (1998) 34: 750-753.
78. VLEMS FA, LADANYI A, GERTLER R et al.: Reliability of quantitative reversetranscriptase- PCR-based detection of tumour cells in the blood between different laboratories using a standardised protocol. Eur. J. Cancer (2003) 39 (3): 388-396. (Pubitemid 36140058)
79. BUSTIN SA: Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J. Mol. Endocrinol. (2002) 29 (1): 23-39. (Pubitemid 34965744)
80. TSAVELLAS G, PATEL H, ALLEN-MERSH TG: Detection and clinical significance of occult tumour cells in colorectal cancer. Br. J. Surg. (2001) 88 (10): 1307-1320. (Pubitemid 32955408)
81. MIYAKE Y, FUJIWARA Y, OHUE M et al.: Quantification of micrometastases in lymph nodes of colorectal cancer using real-time fluorescence polymerase chain reaction. Int. J. Oncol. (2000) 16 (2): 289-293.
82. OBERG AN, LINDMARK GE, ISRAELSSON AC et al.: Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS. Int. J. Cancer (2004) 111 (1): 101-110. (Pubitemid 38859290)
83. HO SB, HYSLOP A, ALBRECHT R et al.: Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen. Clin. Cancer Res. (2004) 10 (17): 5777-5784. (Pubitemid 39180955)
84. BUSTIN SA, GYSELMAN VG, WILLIAMS NS et al.: Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br. J. Cancer (1999) 79 (11-12): 1813-1820. (Pubitemid 29132310)
85. BOSTICK PJ, CHATTERJEE S, CHI DD et al.: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J. Clin. Oncol. (1998) 16 (8): 2632-2640. (Pubitemid 28363026)
86. LLOYD JM, MCIVER CM, STEPHENSON SA et al.: Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Clin. Cancer Res. (2006) 12 (2): 417-423. (Pubitemid 43166130)
87. GUO J, XIAO B, ZHANG X et al.: Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers. J. Mol. Med. (2004) 82 (11): 768-774. (Pubitemid 40022271)
88. ITO S, NAKANISHI H, HIRAI T et al.: Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. Cancer Lett. (2002) 183 (2): 195-203. (Pubitemid 34628424)
89. MIURA M, ICHIKAWA Y, TANAKA K et al.: Real-time PCR (TaqMan PCR) Quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients. Anticancer Res. (2003) 23 (2B): 1271-1276. (Pubitemid 36754087)
90. WONG IH, YEO W, CHAN AT et al.: Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukesstage, serum carcinoembryonic antigen level and tumor progression. Cancer Lett. (2001) 162 (1): 65-73.
91. SCHUSTER R, MAX N, MANN B et al.: Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int. J. Cancer (2004) 108 (2): 219-227. (Pubitemid 37541774)
92. GULLER U, ZAJAC P, SCHNIDER A et al.: Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann. Surg. (2002) 236 (6): 768-775.
93. WYLD DK, SELBY P, PERREN TJ et al.: Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int. J. Cancer (1998) 79 (3): 288-293. (Pubitemid 28262216)
94. PATEL H, LE MARER N, WHARTON RQ et al.: Clearance of circulating tumor cells after excision of primary colorectal cancer. Ann. Surg. (2002) 235 (2): 226-231. (Pubitemid 34111951)
95. FIDLER IJ: The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur. J. Cancer (1973) 9 (3): 223-227.
96. OBRIEN CA, POLLETT A, GALLINGER S et al, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2007) 445 (7123) 106-110. (Pubitemid 46067310)
97. RICCI-VITIANI L, LOMBARDI DG, PILOZZI E et al.: Identification and expansion of human colon-cancer-initiating cells. Nature (2007) 445 (7123): 111-115. (Pubitemid 46067311)
98. WEISS L, DIMITROV DS: A fluid mechanical analysis of the velocity, adhesion, and destruction of cancer cells in capillaries during metastasis. Cell Biophys. (1984) 6 (1): 9-22. (Pubitemid 14058830)
99. CHAMBERS AF, NAUMOV GN, VARGHESE HJ et al.: Critical steps in hematogenous metastasis: an overview. Surg. Oncol. Clin. North Am. (2001) 10 (2): vii , 243-255. (Pubitemid 32472528)
100. BESSA X, CASTELLS A, LACY AM et al.: Laparoscopic-assisted vs. open colectomy for colorectal cancer: Influence on neoplastic cell mobilization. J. Gastrointest Surg. (2001) 5 (1): 66-73. (Pubitemid 33651240)
101. BESSA X, ELIZALDE JI, BOIX L et al.: Lack of prognostic Influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology (2001) 120 (5): 1084-1092. (Pubitemid 32246662)
102. YAMAGUCHI K, TAKAGI Y, AOKI S et al.: Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann. Surg. (2000) 232 (1): 58-65. (Pubitemid 30456551)
103. CHAMBERS AF, GROOM AC, MACDONALD IC: Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer (2002) 2 (8): 563-572. (Pubitemid 37328923)
104. GLAVES D, HUBEN RP, WEISS L: Haematogenous dissemination of cells from human renal adenocarcinomas. Br. J. Cancer (1988) 57 (1): 32-35. (Pubitemid 18067099)
105. MORI M, MIMORI K, UEO H et al.: Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int. J. Cancer (1996) 68 (6): 739-743. (Pubitemid 27062033)
106. WHARTON RQ, JONAS SK, GLOVER C et al.: Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin. Cancer Res. (1999) 5 (12): 4158-4163. (Pubitemid 30013800)
107. WEITZ J, KIENLE P, LACROIX J et al.: Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin. Cancer Res. (1998) 4 (2): 343-348. (Pubitemid 28122748)
108. BROWN DC, PURUSHOTHAM AD, BIRNIE GD et al.: Detection of intraoperative tumor cell dissemination in patients with breast cancer by use of reverse transcription and polymerase chain reaction. Surgery (1995) 117 (1): 95-101.
109. LUNDY J: Anesthesia and surgery: a double-edged sword for the cancer patient. J. Surg. Oncol. (1980) 14 (1): 61-65. (Pubitemid 10105740)
110. ZIV Y, SHOHAT B, GELERENTER I et al.: The Influence of perioperative transfusions on the immunological profile of patients with colorectal adenocarcinoma. Panminerva Med. (1992) 34 (1): 4-12.
111. ATKIN G, CHOPADA A, MITCHELL I: Colorectal cancer metastasis: in the surgeons hands? Int. Semin. Surg. Oncol. (2005) 2 (1): 5.
112. ZETTER BR: The cellular basis of site-specific tumor metastasis. N. Engl. J. Med. (1990) 322 (9): 605-612. (Pubitemid 20190796)
113. SOUTER RG, WELLS C, TARIN D et al.: Surgical and pathologic complications associated with peritoneovenous shunts in management of malignant ascites. Cancer (1985) 55 (9): 1973-1978. (Pubitemid 15116956)
114. WHARTON RQ, PATEL H, JONAS SK et al.: Venesection needle coring increases positive results with RT-PCR for detection of circulating cells expressing CEA mRNA. Clin. Exp. Metast. (2000) 18 (4): 291-294. (Pubitemid 32579396)
115. GHOSSEIN RA, BHATTACHARYA S: Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours. Eur. J. Cancer (2000) 36 (13): 1681-1694. (Pubitemid 30616372)
116. BUSTIN SA, NOLAN T: Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J. Biomol. Tech. (2004) 15 (3): 155-166.
117. HUGGETT J, DHEDA K, BUSTIN S et al.: Real-time RT-PCR normalisation; strategies and considerations. Genes Immun. (2005) 6 (4): 279-284. (Pubitemid 40903399)
118. NOLAN T, HANDS RE, BUSTIN SA: Quantification of mRNA using real-time RT-PCR. Nat. Protocols (2006) 1 (3): 1559-1582.
119. BUSTIN SA, MUELLER R: Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer. Mol. Aspects Med. (2006) 27: 192-223.
120. YAMASAKI M, TAKEMASA I, KOMORI T et al.: The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Int. J. Oncol. (2007) 30 (1): 129-138.
121. HOOS A, NISSAN A, STOJADINOVIC A et al.: Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis. Clin. Cancer Res. (2002) 8 (12): 3841-3849. (Pubitemid 35424778)
122. SHIH W, CHETTY R, TSAO MS: Expression profiling by microarrays in colorectal cancer. Oncol. Rep. (2005) 13 (3): 517-524.
123. DRAGHICI S, KHATRI P, EKLUND AC et al.: Reliability and reproducibility issues in DNA microarray measurements. Trends Genet. (2006) 22 (2): 101-109. (Pubitemid 43152029)
124. LE MASNE DE CHERMONT Q, CHANEAC C, SEGUIN J et al.: Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc. Natl. Acad. Sci. USA (2007) 104 (22): 9266-9271. (Pubitemid 47193021)